Kongressprogram

Assessing emotional states such as pain in non-human animals remains challenging as they are unable meaningfully communicate pain or any other emotional state to those who care for them, i.e., have self-report. Therefore, we must rely on proxy indices of pain, but in many cases, we cannot be sure how these indices relate to the underlying emotional state experienced by the animal.

Practices common on dairy farms around the world are increasingly subject to criticism by consumers, citizens and other stakeholders. In this presentation, I will review different approaches livestock farming industries have applied to counter these criticisms, explain how and why these approaches have largely failed, and then describe a new plan for stakeholder engagement that we believe will more effectively address these concerns. One approach has been to increasingly hide practices from public view – for example, by using “ag-gag” legislation to reduce the chance of people seeing images illustrating contentious practices. Another approach has been to attempt to “educate” our critics in the hope that if they better understood the reasons why these procedures were performed, they would be more willing to accept their use. We will review evidence showing that neither approach is likely to succeed; indeed, efforts to reduce transparency result in reduced trust, and attempts to educate citizens can result in increased rather than decreased concerns. Är live, men kommer att spelas in och läggas upp på plattformen.

Sänds endast live.

Är live, men kommer att spelas in och läggas upp på plattformen.

Challenges of feeding a growing human population has put pressure on all livestock industries to become more efficient. Getting more from less (e.g. more milk from a dairy cow, more pigs per sow per year, more meat from a chicken) is one way of achieving this efficiency and ‘going BIG’ is an aspect of sustainable intensification - but at what cost? Pig production will be used to illustrate the wider consequences of this drive for efficiency, including the welfare and health concerns as well as questioning long-term sustainability and ethical standards. Är live, men kommer att spelas in och läggas upp på plattformen.

Join me for a discussion of the differences in biochemical profiles available for IDEXX point-of-care analyzers including the Catalyst Dx® and Catalyst One®. What tests are included in each? When is a larger panel more likely to identify clinically relevant abnormalities? How can I customize my profile to my patient?

Dr. Andrew Waller är tillgänglig i Nordvaccs monter för frågor mellan 16.45-17.00